Belite Bio, Inc

NASDAQ:BLTE

62 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -0.009-0.008-0.007-0.011-0.007-0.007-0.007-0.002-0.002-0.001-0.002-0.002-0.002-0.002-0.002-0.002-0.001-0.001
Depreciation & Amortization 000000-0.02300000.008000000
Deferred Income Tax 000000-5.35100000000000
Stock Based Compensation 000.0040000.0010.00100-00.0010.0010.0010000
Change In Working Capital 000000-0.4800000.16-0-000-0-0
Accounts Receivables 000000000000000000
Change In Inventory 000000000000000000
Change In Accounts Payables 000000000000000000
Other Working Capital 000000000000-0-000-0-0
Other Non Cash Items 0.0090.0080.0030.0110.0070.0070.0050.0020.0020.0010.0010.0020000-0-0
Operating Cash Flow 000000-5.8530.00100-0.002-1.869-0.002-0.002-0.002-0.002-0.001-0.001
Investing Activities:
Investments In Property Plant And Equipment 0000000.056000-0.019-0.019-0-0-0-0-0.005-0.005
Acquisitions Net 000000000000000000
Purchases Of Investments 000000000000000000
Sales Maturities Of Investments 000000000000000000
Other Investing Activites 000000-0.43100000.019000.0050.0050.0050.005
Investing Cash Flow 000000-0.3760000-0.019-0-0-0-0-0.005-0.005
Financing Activities:
Debt Repayment 000000000000000000
Common Stock Issued 000000000000000.1250.1250.1250.125
Common Stock Repurchased 000000000000000000
Dividends Paid 000000000000000000
Other Financing Activities 00000037.167000-0-0.204-0.204-0.2040.0110.0110.0030.003
Financing Cash Flow 00000037.167000-0-0.204-0.204-0.2040.0110.0110.0030.003
Other Information:
Effect Of Forex Changes On Cash 000000-0.366000-00.022-0-0-0-000
Net Change In Cash 000-2.919.6037.7530.00100-2.069-2.069-2.069-2.0695.96.398-0.4975.9
Cash At End Of Period 00054.557.4042.0890.001004.3364.3364.3364.3366.4056.4050.0076.405